Navigation Links
Halozyme Therapeutics Reports Third Quarter 2011 Financial Results
Date:11/7/2011

cer
(858) 704-8272
kgustafson@halozyme.comHalozyme Therapeutics, Inc.Condensed Consolidated Statements of Operations(unaudited)Three Months EndedNine Months EndedSeptember 30, September 30, 2011201020112010REVENUES:Product sales

$  1,156,903$
98,100$  1,487,822$
95,440Revenues under collaborative agreements

21,785,5253,298,40752,187,4479,356,151Total revenues

22,942,4283,396,50753,675,26910,051,591OPERATING EXPENSES:Cost of product sales

11,7237,214201,67596,413Research and development

13,514,35212,448,86542,647,26535,840,475Selling, general and administrative

4,263,5203,374,06912,237,15210,488,568Total operating expenses

17,789,59515,830,14855,086,09246,425,456OPERATING INCOME (LOSS)

5,152,833(12,433,641)(1,410,823)(36,373,865)Interest and other income, net

12,36024,06556,58625,889NET INCOME (LOSS)

$  5,165,193$ (12,409,576)$ (1,354,237)$ (36,347,976)Net income (loss) per share:Basic

$
.05$
(0.13)$
(0.01)$
(0.39)Diluted

$
.05$
(0.13)$
(0.01)$
(0.39)Shares used in computing net income (loss)  per share:Basic

103,223,35293,626,893102,282,90492,342,665Diluted

105,009,18993,626,893102,282,90492,342,665Halozyme Therapeutics, Inc.Condensed Consolidated Balance SheetsSeptember 30, December 31,20112010(unaudited)ASSETSCurrent assets:Cash and cash equivalents$
,329,358$   83,255,848Accounts receivable6,237,9042,328,268Inventory103,443193,422Prepaid expenses and other assets4,297,8143,720,896Total current assets76,968,51989,498,434Property and equipment, net1,274,7531,846,899Total Assets$
78,243,272$   91,345,333LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable$
,219,905$
3,820,368Accrued expenses8,864,7058,605,569Deferred revenue3,707,7952,917,129Total current liabilities13,792,40515,343,066Deferred revenue, net of current portion36,6
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Halozyme Therapeutics Announces Data From Two Phase 1 Studies of PEGPH20 Demonstrating Targeting of Hyaluronan in Tumor Stroma
2. Halozyme Begins Clinical Trial with HTI-501 in Women with Edematous Fibrosclerotic Panniculopathy
3. Halozyme Therapeutics to Present at the JMP Securities Healthcare Conference on September 28
4. Halozyme Therapeutics to Present Data on its Ultrafast Insulin Programs at the Upcoming American Diabetes Association 71st Scientific Sessions
5. Halozyme Therapeutics to Present at the Jefferies 2011 Global Healthcare Conference on June 9
6. Halozyme Therapeutics Reports First Quarter 2011 Financial Results
7. Halozymes Ultrafast Insulin Generates Faster-In and Faster-Out Profile for Type 1 Diabetes Patients Using Insulin Pumps
8. Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial With Subcutaneous MabThera® (rituximab)
9. Halozyme Therapeutics Reports Third Quarter 2010 Financial Results
10. Halozyme Receives $5.5 Million Payment From Baxter
11. Halozyme Therapeutics Reports 2008 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014  Nektar Therapeutics ... from preclinical studies characterizing the analgesic profiles of ... kappa opioid receptor agonist molecules. The preclinical research ... medicinal chemistry platform. The analgesic properties ... the medical literature. 1,2 Kappa opioid receptors ...
(Date:9/19/2014)... Cereal grain scientists, quality regulators, ... October 5–8, 2014, for the AACC International (AACCI) ... in Providence, Rhode Island. The comprehensive scientific program ... scientists, chemists, microbiologists, nutritionists, and those interested in ... To date, 1,000 attendees have registered for the ...
(Date:9/18/2014)... 18, 2014 Bipartisan passage this week ... designed to stimulate development and commercialization of new technologies ... by leaders of SPIE, the international society for ... Manufacturing and Innovation (RAMI) Act, now moves to the ... said they are optimistic that it will win passage ...
(Date:9/18/2014)... Worcester, Mass. (PRWEB) September 18, 2014 ... bore of an MRI scanner is currently being tested ... Brigham and Women's Hospital in Boston with the aim ... MRI images, can make prostate cancer biopsies faster, more ... The novel system also has the potential to deliver ...
Breaking Biology Technology:Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 2Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 3Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 4Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 5Latest Research on Cereal Grain Quality, Health Benefits and Food Production to be Presented During the AACC International Annual Meeting 2Latest Research on Cereal Grain Quality, Health Benefits and Food Production to be Presented During the AACC International Annual Meeting 3House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 2House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 3Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 2Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 3Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 4Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 5Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 6
... , , , ... • Cy • Alexa Fluor • TAMRA ... , Flexible and scalable uHTS programs ... fluorescent reagents for the task. This application note describes experiments to assess ...
... Key words: ... Analyzer • IN Cell Developer Toolbox, ... neurite outgrowth, plays a fundamental role in embryonic development, neuronal differentiation, ... neuropathological disorders as well as neuronal injury and regeneration. A variety ...
... , ... CypHer ™ 5, a pH sensitive dye, has ... been used to obtain dose-response and rank-order potency data for ... (2). For live-cell receptor internalization studies, an enhanced version of ...
Cached Biology Technology:Performance of fluorescent dyes with LEADseeker Multimodality Imaging System 2Performance of fluorescent dyes with LEADseeker Multimodality Imaging System 3Neurite outgrowth cell-by-cell analysis using the IN Cell Developer Toolbox 2Neurite outgrowth cell-by-cell analysis using the IN Cell Developer Toolbox 3Neurite outgrowth cell-by-cell analysis using the IN Cell Developer Toolbox 4Neurite outgrowth cell-by-cell analysis using the IN Cell Developer Toolbox 5Neurite outgrowth cell-by-cell analysis using the IN Cell Developer Toolbox 6Screening for potential beta 2-adrenergic receptor antagonists using CypHer5E and IN Cell Analyzer 1000 2Screening for potential beta 2-adrenergic receptor antagonists using CypHer5E and IN Cell Analyzer 1000 3Screening for potential beta 2-adrenergic receptor antagonists using CypHer5E and IN Cell Analyzer 1000 4Screening for potential beta 2-adrenergic receptor antagonists using CypHer5E and IN Cell Analyzer 1000 5Screening for potential beta 2-adrenergic receptor antagonists using CypHer5E and IN Cell Analyzer 1000 6
(Date:9/18/2014)... of Americans to undertake jaunts into the countryside each year ... within a century, according to new research. , Climate change ... United States as summer temperatures linger later into the year, ... and Biogeography . For instance, the paper birch a ... Hampshire could change color one to three weeks later ...
(Date:9/18/2014)... Va.Sept. 18, 2014Many Americans across racial and ethnic ... greatest impact on their day-to-day life, more so ... hearing and speech (57% of African-Americans, 49% of ... Hispanics). When asked which disease or ailment is ... ranked first among African-Americans followed by AIDS/HIV. ...
(Date:9/18/2014)... September 18, 2014 Elsevier, a world-leading provider ... services, and the Australasian Research Management Society (ARMS), ... scientists at the 5th Scopus Young Researcher of ... earlier today at the National Convention Centre and ... was attended by guests representing Australia,s and New ...
Breaking Biology News(10 mins):Fall foliage season may be later, but longer on warmer Earth 2Fall foliage season may be later, but longer on warmer Earth 3Fall foliage season may be later, but longer on warmer Earth 4Americans rate losing eyesight as having greatest impact on their lives 2Americans rate losing eyesight as having greatest impact on their lives 3Elsevier and Australasian Research Management Society award scientists at Scopus ceremony 2
... Australian scientists studying the impact obesity has on ... before conceiving to assist with fetal development. ... of Zoology have discovered that a father,s obesity ... pregnancy success and reduced placental development. ...
... LONDON, ON The impact of bipolar disorder during pregnancy ... new study from Lawson Health Research Institute and Western University ... prospective research. Bipolar disorder is characterized by depression, ... its episodes are often concentrated during the height of the ...
... Research by Nosang Myung, a professor at ... Engineering, has enabled a Riverside company to develop ... quantities of harmful airborne substances. Nano Engineered ... completed the prototype which is based on intellectual ...
Cached Biology News:Thinking about kids? Man, you gotta shed the kilos 2Lawson researcher sings the baby blues 2'Electronic nose' prototype developed 2
... CELlulose) was developed in the late 1960s ... of the earliest commercial pioneers of immunoassay ... range in 1987. Sac-Cel rapidly found favour ... own "in house" radioimmunoassays, and became a ...
Determine relative degree of protein binding to phosphoinositides...
PA coated Agarose beads LPA Beads...
Mouse monoclonal antibody to RNase L...
Biology Products: